Pathology

Grants

Grants per year 2000 2001 2007 2009 2010 2012 2014 2016 2017 2018 2019 2020 2021 2022 2028

• 1 Not started
• 143 Active
• 440 Finished

Grants per year

Search results

• Finished

  PARP inhibition and tumor immunity

  Zhang, B., Fang, D. & Sosman, J. A.

  AbbVie Inc.

  9/29/17 → 9/29/19

  Project: Research project

  • PARP Inhibitor 100%
  • tumors 100%
  • Poly ADP Ribose Polymerase 50%
  • Combination Therapy 50%
  • Myeloid-Derived Suppressor Cell 50%

• Mechanisms underlying disruption of intestinal epithelial barrier in critical illness

  Tan, X., Bu, H., Chou, P. M. & Wang, X.

  National Institute of General Medical Sciences

  9/15/17 → 8/31/20

  Project: Research project

• Mechanisms underlying disruption of intestinal epithelial barrier in critical illness

  Chou, P. M. & Wang, X.

  National Institute of General Medical Sciences

  9/15/17 → 8/31/20

  Project: Research project

• Blood Tests to Screen for Colon and Pancreatic Cancer

  Yang, G.

  The University of Chicago, National Center for Advancing Translational Sciences

  9/6/17 → 9/5/18

  Project: Research project

  • colon 100%
  • blood 100%
  • pancreas 50%
  • medical centers 50%
  • cancer 50%

• Mutation and Expression Analysis of MUC Gene Family to Define Atypical Leiomyoma as A Precursor Lesion of Uterine Leiomyosarcoma

  Wei, J.

  Northwestern Memorial Hospital

  9/1/17 → 8/31/19

  Project: Research project

  • Leiomyosarcoma 100%
  • Angioleiomyoma 84%
  • Gene Mutation 46%
  • gene mutations 46%
  • genes 23%

• Function of Desmoglein 1/Pemphigus Foliaceus Antigen

  Green, K. J., Johnson, J. L. P. & Nekrasova, O.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  9/1/17 → 8/31/22

  Project: Research project

  • Desmoglein 1 100%
  • Desmoglein-1 90%
  • Differentiation 60%
  • tissues 50%
  • Tissues 50%

• Neutrophil microRNAs promote genomic instability and carcinogenesis in inflamed intestinal tissue

  Sumagin, R. & Butin-Israeli, V.

  Northwestern Memorial Hospital, Digestive Health Foundation

  9/1/17 → 8/31/18

  Project: Research project

  • tissues 100%
  • Tissues 100%
  • Carcinogenesis 71%
  • Granulocyte 71%
  • Serositis 57%

• Role of C10orfl12 in Prostate Cancer

  Yu, J., Zhao, C., Yang, X. J. & Zhao, C.

  U.S. Army Medical Research and Materiel Command

  9/1/17 → 8/31/22

  Project: Research project

  • cancer 100%
  • prostate 90%
  • EZH2 60%
  • proteins 40%
  • genes 20%

• Loss of ZDHHC-medicated Scribble palmitoylation disrupts cell polarity and promotes prostate cancer progression

  Yu, J., Wei, J. & Zhao, C.

  U.S. Army Medical Research and Materiel Command

  7/15/17 → 7/14/22

  Project: Research project

  • prostate 100%
  • cancer 90%
  • Prostate Cancer 81%
  • Cell Polarity 45%
  • Palmitoylation 45%

• Tissue Factor as a Key Determinant of IDH1 Mutant versus IDH1 Wild-type Glioma Thrombosis and Malignancy

  Horbinski, C. M. & James, C. D.

  National Institute of Neurological Disorders and Stroke

  7/1/17 → 6/30/22

  Project: Research project

  • gliomas 100%
  • Ganglioglioma 90%
  • tissues 63%
  • Thromboplastin 59%
  • Tissue Factor 59%

• Carcinogenesis Training Program

  Green, K. J. & Crispino, J. D.

  National Cancer Institute

  7/1/17 → 6/30/22

  Project: Research project

  • Students 100%
  • Student 100%
  • Cancer 90%
  • cancer 90%
  • Athletic Training 72%

• Inflammatory arthritis: mechanistic insights into initiation and progression

  Pope, R. M., Bi, Y., Fang, D., Huang, Q., Misharin, A., Perlman, H. R. & Winter, D. R.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  7/1/17 → 5/31/22

  Project: Research project

  • arthritis 100%
  • Rheumatoid Arthritis 63%
  • Inflammatory Arthritis 63%
  • mice 52%
  • Mouse 52%

• The role of Plek2 in the pathogenesis of myeloproliferative neoplasms

  Ji, P.

  Leukemia & Lymphoma Society

  7/1/17 → 6/30/22

  Project: Research project

  • neoplasms 100%
  • Janus Kinase 90%
  • Pleckstrin 40%
  • bone marrow 20%
  • patients 20%

• Apigenin restores TSP-1 expression in UVB-irradiated keratinocytes

  Tong, X.

  University of Texas M. D. Anderson Cancer Center, National Cancer Institute

  5/15/17 → 2/28/18

  Project: Research project

  • Thrombospondin 1 100%
  • ultraviolet radiation 55%
  • melanomas 30%
  • skin cancer 30%
  • Non Melanoma Skin Cancer 30%

• Aperture Bio bacteriSTAT- Urinary Tract Infection (UTI) Clinical Evaluation to Determine Safety and Effectiveness and Support FDA 510(k)

  Qi, C.

  Aperture Bio

  5/10/17 → 5/10/20

  Project: Research project

• Neural Stem Cell Carriers for Glioblastoma Immunotherapy

  Balyasnikova, I. V., Horbinski, C. M., James, C. D. & Lesniak, M. S.

  National Institute of Neurological Disorders and Stroke

  5/1/17 → 4/30/19

  Project: Research project

  • Glioblastoma 100%
  • glioblastomas 100%
  • Neural Stem Cell 75%
  • stem cells 75%
  • antibodies 75%

• Epigenomic Priming as an Immunotherapy Enhancer in Ovarian Cancer

  Matei, D. E., Kocherginsky, M., Shahabi, S., Wei, J. & Zhang, B.

  U.S. Army Medical Research and Materiel Command

  5/1/17 → 4/30/21

  Project: Research project

  • tumors 100%
  • Guadecitabine 50%
  • Pembrolizumab 50%
  • Therapeutic Procedure 50%
  • antigens 50%

• Biostation CT (Cell Tracker)

  Rappoport, J. Z., Arvanitis, C., Burridge, P., Chandel, N., George, A. L., Getsios, S., Green, K. J., Horiuchi, D., Kessler, J., Lavker, R. M., Mazar, A. P., McNally, E. M., Paller, A., Shilatifard, A., Swanson, G. T. & Wu, J.

  Office of the Director, National Institutes of Health

  4/1/17 → 3/31/18

  Project: Research project

  • Live Cell Imaging 100%
  • Cellular Imaging 100%
  • Incubator 66%
  • Base 66%
  • Microscopy 66%

• Cellular plasticity and equilibrium in GBM progression

  Ahmed, A. U., Horbinski, C. M., James, C. D. & Shilatifard, A.

  National Institute of Neurological Disorders and Stroke

  4/1/17 → 1/31/22

  Project: Research project

  • stem cells 100%
  • cancer 80%
  • equilibrium 80%
  • Cancer Stem Cell 70%
  • Recurrent Disease 60%

• Systemic RNA interference to reactivate p53 tumor suppression

  Stegh, A. H., Horbinski, C. M. & James, C. D.

  National Cancer Institute

  3/1/17 → 2/28/22

  Project: Research project

  • P53 100%
  • glioblastomas 83%
  • nucleic acids 83%
  • Nucleic Acids 83%
  • Glioblastoma Multiforme 83%

• Targeting Plek2 as a Novel Approach for the Treatment of Myeloproliferative Neoplasms

  Ji, P., Gao, J. & Zhao, B.

  Northwestern Memorial Hospital

  1/1/17 → 12/31/17

  Project: Research project

  • Myeloproliferative Neoplasm 100%
  • neoplasms 100%
  • Janus Kinase 55%
  • Therapeutic Procedure 22%
  • Patient 22%

• Beyond PECAM: Mechanisms of Transendothelial Migration

  Muller, W. A., Gonzalez, A. M., Sullivan, D. P. & Thorp, E. B.

  National Heart, Lung, and Blood Institute

  12/15/16 → 2/28/21

  Project: Research project

  • migration 100%
  • Leukocyte 85%
  • cadmium 99 78%
  • CD99 78%
  • White Blood Cell 64%

• Therapeutic intervention of SIRT3 driven luminal B tumors with SOD

  Raparia, K. & Gius, D. R.

  Avon Breast Cancer Crusade LLC

  10/1/16 → 9/30/17

  Project: Research project

  • Woman 100%
  • screening 75%
  • Screening 75%
  • women 50%
  • Care Coordination 50%

• Sirtuins: novel determinants and therapeutic target in systemic sclerosis

  Varga, J., Agrawal, R., Davuluri, R. V., Lee, J., Tourtellotte, W. & Wei, J.

  National Institute on Aging

  9/30/16 → 6/30/19

  Project: Research project

  • Systemic Scleroderma 100%
  • Systemic Sclerosis 100%
  • Sirtuin 90%
  • fibrosis 60%
  • Fibrosis 40%

• Function of Desmoglein 1/Pemphigus Foliaceus Antigen

  Green, K. J. & Getsios, S.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  9/1/16 → 8/31/17

  Project: Research project